首页> 美国卫生研究院文献>Springer Open Choice >Trend and impact of international collaboration in clinical medicine papers published in Malaysia
【2h】

Trend and impact of international collaboration in clinical medicine papers published in Malaysia

机译:马来西亚发表的临床医学论文国际合作的趋势和影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Research collaboration is the way forward in order to improve quality and impact of its research findings. International research collaboration has resulted in international co-authorship in scientific communications and publications. This study highlights the collaborating research and authorship trend in clinical medicine in Malaysia from 2001 to 2010. Malaysian-based author affiliation in the Web of Science (Science Citation Index Expanded) and clinical medicine journals (n = 999) and articles (n = 3951) as of 30th Oct 2011 were downloaded. Types of document analyzed were articles and reviews, and impact factors (IF) in the 2010 Journal Citation Report Science Edition were taken to access the quality of the articles. The number of publications in clinical medicine increased from 4.5 % (n = 178) in 2001 to 23.9 % (n = 944) in 2010. The top three contributors in the subject categories are Pharmacology and Pharmacy (13.9 %), General and Internal Medicine (13.6 %) and Tropical Medicine (7.3 %). By journal tier system: Tier 1 (18.7 %, n = 738), Tier 2 (22.5 %, n = 888), Tier 3 (29.6 %, n = 1170), Tier 4 (27.2 %, n = 1074), and journals without IF (2.1 %, n = 81). University of Malaya was the most productive. Local collaborators accounted for 60.3 % and international collaborations 39.7 %. Articles with international collaborations appeared in journals with higher journal IFs than those without international collaboration. They were also cited more significantly than articles without international collaborations. Citations, impact factor and journal tiers were significantly associated with international collaboration in Malaysia’s clinical medicine publications. Malaysia has achieved a significant number of ISI publications in clinical medicine participation in international collaboration.
机译:研究合作是提高研究成果的质量和影响力的前进方向。国际研究合作促成了科学交流和出版物的国际合著。这项研究着重介绍了2001年至2010年马来西亚临床医学的合作研究和作者趋势。在Web of Science(科学引文索引已扩大)和临床医学期刊(n = 999)和文章(n = 3951)中,马来西亚籍作者的隶属关系),截至2011年10月30日。分析的文档类型为文章和评论,并采用2010 Journal Citation Report Science Edition中的影响因子(IF)来获取文章的质量。临床医学的出版物数量从2001年的4.5%(n = 178)增加到2010年的23.9%(n = 944)。在该学科类别中排名前三的贡献者是药理学和药学(13.9%),普通和内科(13.6%)和热带医学(7.3%)。按日记帐层系统:1级(18.7%,n = 738),2级(22.5%,n = 888),3级(29.6%,n = 1170),4级(27.2%,n = 1074),和没有IF(2.1%,n = 81)的期刊。马来亚大学生产力最高。本地合作者占60.3%,国际合作占39.7%。具有国际合作关系的文章出现在具有比没有国际合作关系的期刊更高的IF的期刊上。与没有国际合作的文章相比,他们的被引用次数还多。引文,影响因子和期刊等级与马来西亚临床医学出版物中的国际合作密切相关。马来西亚在临床医学参与国际合作方面取得了大量ISI出版物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号